Therapeutic Advances in Relapsed/Refractory Multiple Myeloma
Learning Objectives
At the conclusion of this session, the participant should be able to:
- Integrate into professional practice the key updates of the NCCN Guidelines related to multiple myeloma
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center
Available Credit
- 1.00 Case Manager
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician
- 1.00 Tumor Registrar